Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development.


Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
04 2019
Historique:
received: 20 06 2018
revised: 15 10 2018
accepted: 16 10 2018
pubmed: 25 11 2018
medline: 18 12 2019
entrez: 25 11 2018
Statut: ppublish

Résumé

Pathogens comprise a diverse set of immunostimulatory molecules that activate the innate immune system during infection. The immune system recognizes distinct combinations of pathogenic molecules leading to multiple immune activation events that cooperate to produce enhanced immune responses, known as 'immune synergies'. Effective immune synergies are essential for the clearance of pathogens, thus inspiring novel adjuvant design to improve vaccines. We highlight current vaccine adjuvants and the importance of immune synergies to adjuvant and vaccine design. The focus is on new technologies used to study and apply immune synergies to adjuvant and vaccine development. Finally, we discuss how recent findings can be applied to the future design and characterization of synergistic adjuvants and vaccines.

Identifiants

pubmed: 30470547
pii: S0167-7799(18)30291-9
doi: 10.1016/j.tibtech.2018.10.004
pii:
doi:

Substances chimiques

Adjuvants, Immunologic 0
Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-388

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Janine K Tom (JK)

Department of Chemistry, University of California, Irvine, Irvine, CA 92697, USA.

Tyler J Albin (TJ)

Department of Chemistry, University of California, Irvine, Irvine, CA 92697, USA.

Saikat Manna (S)

Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.

Brittany A Moser (BA)

Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.

Rachel C Steinhardt (RC)

Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.

Aaron P Esser-Kahn (AP)

Department of Chemistry, University of California, Irvine, Irvine, CA 92697, USA; Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA. Electronic address: aesserkahn@uchicago.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH